Researchers continue to break new ground.
We are also renowned for our advancements in blood and marrow transplantation as a treatment for chronic myelogenous leukemia. The University of Minnesota is a world leader in the field of hematopoietic stem cell transplantation to treat metabolic disorders. We are one of four BMT centers approved for the NIH umbilical cord blood study . Researchers are incorporating gene therapy and immunotherapy into the transplant process. The hope is that by adding new therapeutic weapons, the procedure can be more effective and safer.